Ascendis Pharma A/SASNDNASDAQ
Loading
Income Before Tax Over TimeExpanding
Percentile Rank46
Studio
Year-over-Year Change

Pre-tax earnings

Latest
$-212.40M
↑ 29% vs avg
Percentile
P46
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-298.26M
Historical baseline
PeriodValueYoY Change
TTM$-212.40M+43.1%
2024$-373.24M+21.3%
2023$-474.14M+17.9%
2022$-577.82M-50.5%
2021$-383.94M+8.4%
2020$-419.17M-92.1%
2019$-218.25M-67.3%
2018$-130.49M-4.9%
2017$-124.37M-81.0%
2016$-68.73M-